Ali Khademhosseini (ChemE 9T9) elected as Fellow of the Royal Society of Canada

Ali Khademhosseini (ChemE 9T9, IBBME MASc 0T1) is one of 93 new Fellows in the Academies of Arts and Humanities, Social Sciences, and Science to have been elected by their peers to the Royal Society of Canada.

Khademhosseini holds faculty appointments in bioengineering and chemical and biomolecular engineering in the Samueli School of Engineering, and radiology in the Geffen School of Medicine. He is the founding director of Center for Minimally Invasive Therapeutics and a member of California NanoSystems Institute.

He has received more than 60 national and international honors for his work in applying bioengineering techniques to applications precision medicine, including the Presidential Early Career Award for Scientists and Engineers, the U.S. government’s highest honor for researchers in the early stages of their career.  He is a fellow of the Canadian Academy of Engineering, American Institute of Medical and Biological Engineering; International Academy of Medical and Biological Engineering; Biomedical Engineering Society; Royal Society of Chemistry; Biomaterials Science and Engineering; Materials Research Society; and the American Association for the Advancement of Science.

Founded in 1882, the Royal Society of Canada comprises the Academies of Arts, Humanities and Sciences, and the College of New Scholars, Artists and Scientists. The organization recognizes excellence, advises the government and the larger society, and promotes a culture of knowledge and innovation in Canada and with other national academies around the world.

New fellows will be officially honored in November at the society’s Celebration of Excellence and Engagement, to be held in Ottawa.